换一批
换一批Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2-positive breast cancer cells in a synergistic manner.
作者：
主题词
抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞凋亡(Apoptosis);硼酸化物(Boronic Acids);乳腺肿瘤(Breast Neoplasms);细胞系, 肿瘤(Cell Line, Tumor);细胞核(Cell Nucleus);周期素依赖激酶抑制剂p27(Cyclin-Dependent Kinase Inhibitor p27);抗药性, 肿瘤(Drug Resistance, Neoplasm);药物协同作用(Drug Synergism);人类(Humans);NF-κB(NF-kappa B);吡嗪类(Pyrazines)
DOI
10.1158/1535-7163.MCT-06-0104
PMID
17148762
发布时间
2020-09-30
- 浏览14
Molecular cancer therapeutics
3042-51页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
